Efficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.

NCT04984408 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

8825

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Disease

Interventions

BIOLOGICAL: BBIBP-CorV - Inactivated SARS-CoV-2 vaccine (Vero cell)
BIOLOGICAL: influenza season quadrivalent Influenza Vaccine (Flu Quadrivalent)

Sponsor

International Vaccine Institute